Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will participate at the Oppenheimer MedTech, Tools & Diagnostics Summit on Wednesday, May 26, 2021. Interested parties may access the pre-recorded and archived webcast of the presentation for 90 days...

Click to view original post